Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Endocrinological Investigation|July 5, 2003
Insulin and GH secretion in adolescent girls with irregular cycles: polycystic vs multifollicular ovariesP Villa, A Rossodivita, A M Fulghesu, et al.
Journal of Endocrinological Investigation|March 27, 2019
"Hormone of darkness" and human reproductive process: direct regulatory role of melatonin in human corpus luteumE Scarinci, A Tropea, G Notaristefano, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 31, 1998
Endothelin-1: expression and role in human corpus luteumR Apa, F Miceli, D de Feo, et al.
Journal of Endocrinological Investigation|July 1, 1997
The hypothalamic-pituitary-luteal axis in women: effects of long-term orally active opioid antagonist (naltrexone) administrationA M Fulghesu, A Lanzone, R Apa, et al.
Biology of Reproduction|November 22, 1997
Effect of pituitary adenylate cyclase-activating peptide on meiotic maturation in follicle-enclosed, cumulus-enclosed, and denuded rat oocytesR Apa, A Lanzone, M Mastrandrea, et al.
Journal of Endocrinological Investigation|August 18, 2001
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective studyA M Fulghesu, M Ciampelli, C Belosi, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 1999
Paracrine regulation of insulin-like growth factor I (IGF-I) an IGF-II on prostaglandins F2alpha and E2 synthesis by human corpus luteum in vitro: a possible balance of luteotropic and luteolytic effectsR Apa, F Miceli, E Pierro, et al.
Fertility and Sterility|August 1, 1996
Insulin-like growth factor (IGF)-I and IGF-II stimulate progesterone production by human luteal cells: role of IGF-I as mediator of growth hormone actionR Apa, N Di Simone, E Ronsisvalle, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 1998
Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndromeM Guido, V Pavone, M Ciampelli, et al.
Hormone Research|December 12, 2001
Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatmentA M Fulghesu, R Apa, C Belosi, et al.
Pageof 6